Summit Creek Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.99M Sell
118,956
-106,938
-47% -$4.48M 2.38% 13
2026
Q1
$7.28M Sell
225,894
-12,623
-5% -$467K 1.49% 36
2025
Q4
$10M Sell
238,517
-9,608
-4% -$387K 1.58% 35
2025
Q3
$8.52M Buy
+248,125
New +$7.12M 1.24% 40

Other funds holding VCYT

Summit Creek Advisors's VCYT Position: Q2 2026 in Review

Summit Creek Advisors reduced its Veracyte (VCYT) stake by 47% in Q2 2026, selling an estimated $4.48M and leaving 118,956 shares worth $6.99M. The position accounts for 2.38% of the portfolio, ranked #13.

Summit Creek Advisors first reported a position in VCYT in Q3 2025 and has held it in 4 quarters since. The position peaked at $10M in Q4 2025. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Summit Creek Advisors held 118,956 shares of Veracyte worth $6.99M as of Q2 2026.
  • Summit Creek Advisors sold 106,938 Veracyte shares in Q2 2026, an estimated $4.48M.
  • Veracyte made up 2.38% of Summit Creek Advisors's portfolio in Q2 2026, its #13 holding.
  • Summit Creek Advisors first reported a position in Veracyte in Q3 2025 and has held it in 4 quarters since.
  • Summit Creek Advisors's Veracyte position peaked at $10M in Q4 2025.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Summit Creek Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.